MartÃnez-Baz, I.; Fernández-Huerta, M.; Navascués, A.; Pozo, F.; Trobajo-SanmartÃn, C.; Casado, I.; Echeverria, A.; Ezpeleta, C.; Castilla, J.
Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023. Vaccines 2023, 11, 1478.
https://doi.org/10.3390/vaccines11091478
AMA Style
MartÃnez-Baz I, Fernández-Huerta M, Navascués A, Pozo F, Trobajo-SanmartÃn C, Casado I, Echeverria A, Ezpeleta C, Castilla J.
Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023. Vaccines. 2023; 11(9):1478.
https://doi.org/10.3390/vaccines11091478
Chicago/Turabian Style
MartÃnez-Baz, Iván, Miguel Fernández-Huerta, Ana Navascués, Francisco Pozo, Camino Trobajo-SanmartÃn, Itziar Casado, Aitziber Echeverria, Carmen Ezpeleta, and Jesús Castilla.
2023. "Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023" Vaccines 11, no. 9: 1478.
https://doi.org/10.3390/vaccines11091478
APA Style
MartÃnez-Baz, I., Fernández-Huerta, M., Navascués, A., Pozo, F., Trobajo-SanmartÃn, C., Casado, I., Echeverria, A., Ezpeleta, C., & Castilla, J.
(2023). Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023. Vaccines, 11(9), 1478.
https://doi.org/10.3390/vaccines11091478
